Skip to main content
Top
Published in: BMC Infectious Diseases 1/2007

Open Access 01-12-2007 | Research article

Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners

Authors: Giuseppe La Torre, Luca Miele, Giacomina Chiaradia, Alice Mannocci, Manuela Reali, Giovanni Gasbarrini, Elisabetta De Vito, Antonio Grieco, Walter Ricciardi

Published in: BMC Infectious Diseases | Issue 1/2007

Login to get access

Abstract

Background

The coinfections HIV/HCV/HBV are an important health issue in penitentiary communities. The aim of the study was to examine HIV, HBV and HCV coinfections determinants amongst prisoners in the jails of Southern Lazio (Central Italy), in the period 1995–2000.

Methods

Diagnosis of seropositivities for HIV, HBV and HCV was made using ELISA method. A multiple logistic regression analysis was conducted to verify the influence of socio-demographic factors on the HIV/HBV/HCV coinfections.

Results

HIV/HCV, HBV/HCV and HIV/HBV coinfections were detected in 42 (4%), 203 (17.9%) and 31 (2.9%) inmates, respectively. These coinfections are significantly associated with the status of drug addiction (OR = 16.02; p = 0.012; OR = 4.15; p < 0.001; OR = 23.57; p = 0.002), smoking habits (OR = 3.73; p = 0.033; OR = 1.42; p = 0.088; OR = 4.25; p = 0.053) and Italian nationality (OR = 7.05; p = 0.009; OR = 2.31; p < 0.001; OR = 4.61; p = 0.04).

Conclusion

The prevalence of HIV, HBV and HCV seropositivity in jails suggests that information and education programs for inmates could be useful to reduce the spread of such infections.
Literature
1.
go back to reference Highleyman L: HIV and hepatitis C coinfection. BETA. 2003, 15: 32-44.PubMed Highleyman L: HIV and hepatitis C coinfection. BETA. 2003, 15: 32-44.PubMed
2.
go back to reference Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al: Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004, 94: 1218-23.CrossRefPubMedPubMedCentral Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al: Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004, 94: 1218-23.CrossRefPubMedPubMedCentral
3.
go back to reference Giotakos O, Bourtsoukli P, Paraskeyopoulou T, Spandoni P, Stasinos S, Boulougouri D, et al: Prevalence and risk factors of HIV, hepatitis B and hepatitis C in a forensic population of rapists and child molesters. Epidemiol Infect. 2003, 130: 497-500.PubMedPubMedCentral Giotakos O, Bourtsoukli P, Paraskeyopoulou T, Spandoni P, Stasinos S, Boulougouri D, et al: Prevalence and risk factors of HIV, hepatitis B and hepatitis C in a forensic population of rapists and child molesters. Epidemiol Infect. 2003, 130: 497-500.PubMedPubMedCentral
4.
go back to reference Solomon L, Flynn C, Muck K, Vertefeuille J: Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004, 81: 25-37.CrossRefPubMedPubMedCentral Solomon L, Flynn C, Muck K, Vertefeuille J: Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health. 2004, 81: 25-37.CrossRefPubMedPubMedCentral
5.
go back to reference Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM: Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol. 1998, 14: 555-61. 10.1023/A:1007410707801.CrossRefPubMed Santana Rodriguez OE, Male Gil ML, HernandezSantana JF, Liminana Canal JM, Martin Sanchez AM: Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol. 1998, 14: 555-61. 10.1023/A:1007410707801.CrossRefPubMed
6.
go back to reference Altice FL, Mostashari F, Selwyn PA, Checko PJ, Singh R, Tanguay S, et al: Predictors of HIV infection among newly sentenced male prisoners. JAIDS. 1998, 18: 444-53.PubMed Altice FL, Mostashari F, Selwyn PA, Checko PJ, Singh R, Tanguay S, et al: Predictors of HIV infection among newly sentenced male prisoners. JAIDS. 1998, 18: 444-53.PubMed
7.
8.
go back to reference Buavirat A, Page-Shafer K, van Griensven GJP, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A: Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003, 326: 308-12. 10.1136/bmj.326.7384.308.CrossRefPubMedPubMedCentral Buavirat A, Page-Shafer K, van Griensven GJP, Mandel JS, Evans J, Chuaratanaphong J, Chiamwongpat S, Sacks R, Moss A: Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ. 2003, 326: 308-12. 10.1136/bmj.326.7384.308.CrossRefPubMedPubMedCentral
9.
go back to reference Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB: Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop. 2000, 33: 27-30. 10.1590/S0037-86822000000100004.CrossRefPubMed Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB: Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuacu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop. 2000, 33: 27-30. 10.1590/S0037-86822000000100004.CrossRefPubMed
10.
go back to reference Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al: Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS. 1996, 10: 1009-15.CrossRefPubMed Dufour A, Alary M, Poulin C, Allard F, Noel L, Trottier G, et al: Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS. 1996, 10: 1009-15.CrossRefPubMed
11.
go back to reference Edwards A, Curtis S, Sherrard J: Survey of risk behaviour and HIV prevalence in an English prison. Int J STD AIDS. 1999, 10: 464-6. 10.1258/0956462991914474.CrossRefPubMed Edwards A, Curtis S, Sherrard J: Survey of risk behaviour and HIV prevalence in an English prison. Int J STD AIDS. 1999, 10: 464-6. 10.1258/0956462991914474.CrossRefPubMed
12.
14.
go back to reference Martin Sanchez V, Cayla Buqueras JA, Gonzales Moris ML, Herrero Alonso LE, Vicente Perez R: Evaluation of the prevalence of HIV infection in prison inmates at the time of their imprisonment during the period 1991–1995. Rev Esp Salud Publica. 1997, 71: 269-80.CrossRefPubMed Martin Sanchez V, Cayla Buqueras JA, Gonzales Moris ML, Herrero Alonso LE, Vicente Perez R: Evaluation of the prevalence of HIV infection in prison inmates at the time of their imprisonment during the period 1991–1995. Rev Esp Salud Publica. 1997, 71: 269-80.CrossRefPubMed
15.
go back to reference McDonald AM, Ryan JW, Brown PR, Manners CJ, Falconer AD, Kinnear RC, et al: HIV prevalence at reception into Australian prisons, 1991–1997. Med J Aust. 1999, 171: 18-21.PubMed McDonald AM, Ryan JW, Brown PR, Manners CJ, Falconer AD, Kinnear RC, et al: HIV prevalence at reception into Australian prisons, 1991–1997. Med J Aust. 1999, 171: 18-21.PubMed
16.
go back to reference Allwright S, Bradley F, Long J, Thornton L, Parry J: Prevalence of antibodies to hepatitis B, Hepatitis C, and risk factor in Irish prisoners: result of a national cross sectional survey. BMJ. 2000, 321: 78-82. 10.1136/bmj.321.7253.78.CrossRefPubMedPubMedCentral Allwright S, Bradley F, Long J, Thornton L, Parry J: Prevalence of antibodies to hepatitis B, Hepatitis C, and risk factor in Irish prisoners: result of a national cross sectional survey. BMJ. 2000, 321: 78-82. 10.1136/bmj.321.7253.78.CrossRefPubMedPubMedCentral
17.
go back to reference Anastassopoulou CG, Paraskevis D, Sypsa V, Psichoqiou M, Katsoulidou A, Tassopoulos N, et al: Prevalence Patterns and Genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. JMV. 1998, 56: 246-52. 10.1002/(SICI)1096-9071(199811)56:3<246::AID-JMV12>3.0.CO;2-C. Anastassopoulou CG, Paraskevis D, Sypsa V, Psichoqiou M, Katsoulidou A, Tassopoulos N, et al: Prevalence Patterns and Genotypes of GB virus C/hepatitis G virus among imprisoned intravenous drug users. JMV. 1998, 56: 246-52. 10.1002/(SICI)1096-9071(199811)56:3<246::AID-JMV12>3.0.CO;2-C.
18.
go back to reference Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW: Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997, 166: 127-30.PubMed Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW: Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997, 166: 127-30.PubMed
19.
go back to reference Crofts N, Stewart T, Hearne P, Yi Ping X, Breschkin A, Locarnini S: Spread of bloodborne viruses among Australian prison entrants. BMJ. 1995, 310: 285-8.CrossRefPubMedPubMedCentral Crofts N, Stewart T, Hearne P, Yi Ping X, Breschkin A, Locarnini S: Spread of bloodborne viruses among Australian prison entrants. BMJ. 1995, 310: 285-8.CrossRefPubMedPubMedCentral
20.
go back to reference Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J: HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM. 2000, 93: 113-9. 10.1093/qjmed/93.2.113.CrossRefPubMed Ford PM, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J: HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. QJM. 2000, 93: 113-9. 10.1093/qjmed/93.2.113.CrossRefPubMed
21.
go back to reference Long J, Allwright S, Barry J, Reynolds SR, Thornton L, Bradley F, et al: Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ. 2001, 323: 1209-13. 10.1136/bmj.323.7323.1209.CrossRefPubMedPubMedCentral Long J, Allwright S, Barry J, Reynolds SR, Thornton L, Bradley F, et al: Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey. BMJ. 2001, 323: 1209-13. 10.1136/bmj.323.7323.1209.CrossRefPubMedPubMedCentral
22.
go back to reference Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A, Tassopoulos N, et al: A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction. 1998, 93: 243-51. 10.1046/j.1360-0443.1998.9322438.x.CrossRefPubMed Malliori M, Sypsa V, Psichogiou M, Touloumi G, Skoutelis A, Tassopoulos N, et al: A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction. 1998, 93: 243-51. 10.1046/j.1360-0443.1998.9322438.x.CrossRefPubMed
23.
go back to reference Ruiz JD, Molitor F, Sun RK, Mikanda J, Facer M, Colford JM, et al: Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med. 1999, 170: 156-60.PubMedPubMedCentral Ruiz JD, Molitor F, Sun RK, Mikanda J, Facer M, Colford JM, et al: Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med. 1999, 170: 156-60.PubMedPubMedCentral
24.
go back to reference Singh S, Prasad R, Mohanty A: High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Int J STD AIDS. 1999, 10: 475-8. 10.1258/0956462991914357.CrossRefPubMed Singh S, Prasad R, Mohanty A: High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India. Int J STD AIDS. 1999, 10: 475-8. 10.1258/0956462991914357.CrossRefPubMed
25.
go back to reference Dolan KA, Wodak A: HIV transmission in a prison system in an Australian State. Med J Aust. 1999, 171: 14-7.PubMed Dolan KA, Wodak A: HIV transmission in a prison system in an Australian State. Med J Aust. 1999, 171: 14-7.PubMed
26.
go back to reference Margara A: La tossicodipendenza negli Istituti di pena. Proceedings First National Conference on Addiction, Palermo. 24–26 June 1993 Margara A: La tossicodipendenza negli Istituti di pena. Proceedings First National Conference on Addiction, Palermo. 24–26 June 1993
27.
go back to reference Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, et al: Seroprevalence of HIV, HCV and Syphilis in Brazilian prisoners: Preponderance of parenteral transmission. Eur J Epidemiol. 1999, 15: 439-45. 10.1023/A:1007523027876.CrossRefPubMed Massad E, Rozman M, Azevedo RS, Silveira AS, Takey K, Yamamoto YI, et al: Seroprevalence of HIV, HCV and Syphilis in Brazilian prisoners: Preponderance of parenteral transmission. Eur J Epidemiol. 1999, 15: 439-45. 10.1023/A:1007523027876.CrossRefPubMed
28.
go back to reference O'Sullivan BG, Levy MH, Dolan KA, Post JJ, Barton SG, Dwyer DE, et al: Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. Med J Aust. 2003, 178: 546-9.PubMed O'Sullivan BG, Levy MH, Dolan KA, Post JJ, Barton SG, Dwyer DE, et al: Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons. Med J Aust. 2003, 178: 546-9.PubMed
29.
go back to reference Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M: Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect. 1999, 123: 95-102. 10.1017/S0950268899002538.CrossRefPubMedPubMedCentral Pallas J, Farinas-Alvarez C, Prieto D, Llorca J, Delgado-Rodriguez M: Risk factors for monoinfections and coinfections with HIV, hepatitis B and hepatitis C viruses in northern Spanish prisoners. Epidemiol Infect. 1999, 123: 95-102. 10.1017/S0950268899002538.CrossRefPubMedPubMedCentral
30.
go back to reference Pont J, Strutz H, Kahl W, Salzner G: HIV epidemiology and risk behaviour promoting HIV transmission in Austrian prisons. Eur J Epidemiol. 1994, 10: 285-9. 10.1007/BF01719351.CrossRefPubMed Pont J, Strutz H, Kahl W, Salzner G: HIV epidemiology and risk behaviour promoting HIV transmission in Austrian prisons. Eur J Epidemiol. 1994, 10: 285-9. 10.1007/BF01719351.CrossRefPubMed
31.
go back to reference Samuel MC, Doherty PM, Bulterys M, Jenison SA: Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001, 127: 475-84.CrossRefPubMedPubMedCentral Samuel MC, Doherty PM, Bulterys M, Jenison SA: Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001, 127: 475-84.CrossRefPubMedPubMedCentral
32.
go back to reference Hammett TM, Harmon MP, Rhodes W: The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health. 2002, 92: 1789-94.CrossRefPubMedPubMedCentral Hammett TM, Harmon MP, Rhodes W: The burden of infectious disease among inmates of and releases from US correctional facilities, 1997. Am J Public Health. 2002, 92: 1789-94.CrossRefPubMedPubMedCentral
33.
go back to reference Weinbaum CM, Sabin KM, Santibanez SS: Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005, 19 (suppl 3): S41-S46. 10.1097/01.aids.0000192069.95819.aa.CrossRefPubMed Weinbaum CM, Sabin KM, Santibanez SS: Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention. AIDS. 2005, 19 (suppl 3): S41-S46. 10.1097/01.aids.0000192069.95819.aa.CrossRefPubMed
34.
go back to reference Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW: Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997, 166: 127-30.PubMed Butler TG, Dolan KA, Ferson MJ, McGuinness LM, Brown PR, Robertson PW: Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997, 166: 127-30.PubMed
35.
go back to reference Crofts N, Stewart T, Hearne P, Yi Ping X, Breschkin A, Locarnini S: Spread of bloodborne viruses among Australian prison entrants. BMJ. 1995, 310: 285-8.CrossRefPubMedPubMedCentral Crofts N, Stewart T, Hearne P, Yi Ping X, Breschkin A, Locarnini S: Spread of bloodborne viruses among Australian prison entrants. BMJ. 1995, 310: 285-8.CrossRefPubMedPubMedCentral
36.
go back to reference Vlahov D, Brewer F, Munoz A, Hall D, Taylor E, Polk BF: Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985–1987. J AIDS. 1989, 2: 283-90. Vlahov D, Brewer F, Munoz A, Hall D, Taylor E, Polk BF: Temporal trends of human immunodeficiency virus type 1 (HIV-1) infection among inmates entering a statewide prison system, 1985–1987. J AIDS. 1989, 2: 283-90.
37.
go back to reference Koulierakis G, Gnardellis C, Agrafiotis D, Power KG: HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction. 2000, 95: 1207-16. 10.1046/j.1360-0443.2000.95812077.x.CrossRefPubMed Koulierakis G, Gnardellis C, Agrafiotis D, Power KG: HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction. 2000, 95: 1207-16. 10.1046/j.1360-0443.2000.95812077.x.CrossRefPubMed
38.
go back to reference Martin V, Cayla JA, Bolea A, Castilla J: Mycobacterium tuberculosis and human immunodeficiency virus coinfection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000, 4: 41-6.PubMed Martin V, Cayla JA, Bolea A, Castilla J: Mycobacterium tuberculosis and human immunodeficiency virus coinfection in intravenous drug users on admission to prison. Int J Tuberc Lung Dis. 2000, 4: 41-6.PubMed
39.
go back to reference Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I: History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997, 6: 1359-66. 10.1093/ije/26.6.1359.CrossRef Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I: History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997, 6: 1359-66. 10.1093/ije/26.6.1359.CrossRef
40.
go back to reference Arrada A, Zak Dit Zbar O, Vasseur V: Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Sante prison, Paris. Ann Med Interne. 2001, 152S: 6-8. Arrada A, Zak Dit Zbar O, Vasseur V: Prevalence of HBV and HCV infections and incidence of HCV infection after 3, 6 and 12 months detention in La Sante prison, Paris. Ann Med Interne. 2001, 152S: 6-8.
42.
go back to reference Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, et al: Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003, 98: 1257-65. 10.1046/j.1360-0443.2003.00466.x.CrossRefPubMed Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, et al: Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction. 2003, 98: 1257-65. 10.1046/j.1360-0443.2003.00466.x.CrossRefPubMed
43.
go back to reference Law 21 October 1999 Act: Definizione dei casi di AIDS conclamato o di grave deficienza immunitaria per i fini di cui alla legge 12 luglio n. 231. (G.U. n° 299 del 22 dicembre 1999). Law 21 October 1999 Act: Definizione dei casi di AIDS conclamato o di grave deficienza immunitaria per i fini di cui alla legge 12 luglio n. 231. (G.U. n° 299 del 22 dicembre 1999).
44.
go back to reference Law 22 June 1999 n. 230 Act: Riordino della medicina penitenziaria, a norma dell'art.5, della legge 30 novembre 1998 (n° 419. G.U n° 132/L del 16 luglio 1999). Law 22 June 1999 n. 230 Act: Riordino della medicina penitenziaria, a norma dell'art.5, della legge 30 novembre 1998 (n° 419. G.U n° 132/L del 16 luglio 1999).
45.
go back to reference Law 12 July 1999 n. 231 Act: Disposizioni in materia di esecuzione della pena, di misure di sicurezza e di misure cautelari nei confronti dei soggetti affetti da AIDS conclamata e da grave deficienza immunitaria o da altra malattia particolarmente grave (G.U n° 167 del 19 luglio 1999). Law 12 July 1999 n. 231 Act: Disposizioni in materia di esecuzione della pena, di misure di sicurezza e di misure cautelari nei confronti dei soggetti affetti da AIDS conclamata e da grave deficienza immunitaria o da altra malattia particolarmente grave (G.U n° 167 del 19 luglio 1999).
46.
go back to reference La Torre G, De Vito E, Capelli G, et al: Occurrence and correlates of HIV and hepatitis B and C virus infections among prisoners of Southern Lazio, Italy. Eur J Public Health. 2004, 14S: 67-8. La Torre G, De Vito E, Capelli G, et al: Occurrence and correlates of HIV and hepatitis B and C virus infections among prisoners of Southern Lazio, Italy. Eur J Public Health. 2004, 14S: 67-8.
47.
go back to reference La Torre G, Vezzo D, Arcese R, Bongiovanni C, Capelli G, Ricciardi G: Occurrence and correlates of HIV and Hepatitis B/C virus infections among prisoners of Southern Lazio, Italy. Ital J Public Health. 2004, 33-9. La Torre G, Vezzo D, Arcese R, Bongiovanni C, Capelli G, Ricciardi G: Occurrence and correlates of HIV and Hepatitis B/C virus infections among prisoners of Southern Lazio, Italy. Ital J Public Health. 2004, 33-9.
48.
go back to reference Hosmer DW, Lemeshow S: Applied logistic regression. 1989, New York : Wiley & Sons new edition Hosmer DW, Lemeshow S: Applied logistic regression. 1989, New York : Wiley & Sons new edition
49.
go back to reference Bonaventura ME, Marchili M, Di Nardo V: Infezione da HIV e da virus epatici nella popolazione carceraria e nelle Forze dell'Ordine della Provincia di Rieti. Ann Ig. 1996, 8: 291-5.PubMed Bonaventura ME, Marchili M, Di Nardo V: Infezione da HIV e da virus epatici nella popolazione carceraria e nelle Forze dell'Ordine della Provincia di Rieti. Ann Ig. 1996, 8: 291-5.PubMed
50.
go back to reference Babudieri S, Longo B, Sarmati L, Stagnini G, Dori L, Suligoi B, et al: Correlates of HIV, HBV, and HCV Infections in a Prison Inmate Population: Results From a Multicentre Study in Italy. J Medical Virology. 2005, 76: 311-7. 10.1002/jmv.20375.CrossRef Babudieri S, Longo B, Sarmati L, Stagnini G, Dori L, Suligoi B, et al: Correlates of HIV, HBV, and HCV Infections in a Prison Inmate Population: Results From a Multicentre Study in Italy. J Medical Virology. 2005, 76: 311-7. 10.1002/jmv.20375.CrossRef
51.
go back to reference Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F: HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests. Epidemiol Prev. 2004, 28: 163-8.PubMed Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F: HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests. Epidemiol Prev. 2004, 28: 163-8.PubMed
52.
go back to reference Alvarado-Esquivel C, Sablon E, Martinez-Garcia S, Estrada-Martinez S: Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol Infect. 2005, 133: 679-85. 10.1017/S0950268805003961.CrossRefPubMedPubMedCentral Alvarado-Esquivel C, Sablon E, Martinez-Garcia S, Estrada-Martinez S: Hepatitis virus and HIV infections in inmates of a state correctional facility in Mexico. Epidemiol Infect. 2005, 133: 679-85. 10.1017/S0950268805003961.CrossRefPubMedPubMedCentral
53.
go back to reference Thaisri H, Lerwitworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, et al: HIV infection and risk factors among Bangkok prisoners, Thailand:a prospective cohort study. BMC Infectious Diseases. 2003, 3: 25-10.1186/1471-2334-3-25.CrossRefPubMedPubMedCentral Thaisri H, Lerwitworapong J, Vongsheree S, Sawanpanyalert P, Chadbanchachai C, Rojanawiwat A, et al: HIV infection and risk factors among Bangkok prisoners, Thailand:a prospective cohort study. BMC Infectious Diseases. 2003, 3: 25-10.1186/1471-2334-3-25.CrossRefPubMedPubMedCentral
54.
go back to reference Rothon DA, Mathias RG, Schechter MT: Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J. 1994, 151: 781-7. Rothon DA, Mathias RG, Schechter MT: Prevalence of HIV infection in provincial prisons in British Columbia. Can Med Assoc J. 1994, 151: 781-7.
57.
go back to reference WHO Europe: Health in prisons. A WHO Guide to the essentials in prison health. 2007, World Health Organization WHO Europe: Health in prisons. A WHO Guide to the essentials in prison health. 2007, World Health Organization
Metadata
Title
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners
Authors
Giuseppe La Torre
Luca Miele
Giacomina Chiaradia
Alice Mannocci
Manuela Reali
Giovanni Gasbarrini
Elisabetta De Vito
Antonio Grieco
Walter Ricciardi
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2007
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-7-100

Other articles of this Issue 1/2007

BMC Infectious Diseases 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.